Atridia Pty Ltd.
35
3
4
28
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
5.7%
2 terminated/withdrawn out of 35 trials
93.3%
+6.8% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 28 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (35)
A Trial of SHR-1139 in Healthy Volunteers
Role: lead
A Trial of SHR-2173 in Healthy Volunteers
Role: lead
To Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-6209 in Subjects With HR-Positive/HER2-Negative Solid Tumor
Role: lead
A Trial of HRS-5817 in Obese Participants
Role: lead
A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer
Role: lead
A Trial of HRS-1893 in Healthy Volunteers
Role: lead
A Study of SHR-A1811 in Subjects With Advanced Malignant Solid Tumors
Role: collaborator
A Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease
Role: lead
Phase 1 Study to Evaluate PK, Safety, and Tolerability of HRS-5041 in Healthy Caucasian Male Participants
Role: lead
A Trial of SHR-4602 Infusion in Patients With SHR-4602 in Subjects With HER2-expressing or HER2-mutated Locally Advanced or Metastatic Solid Tumors
Role: lead
Phase 1 Study of HRS-9231 Safety and Pharmacokinetics in Healthy Caucasians
Role: lead
A Trial of SHR-A1921 for Injection in Subjects With Advanced Solid Tumors
Role: lead
Phase I Study of SHR-2002 + SHR-1316 in Patients With Advanced Malignant Tumors
Role: lead
A Trial of SHR-1905 in Healthy Subjects
Role: lead
A Trial of HRS-7085 Tablet in Healthy Participants With and Without Food Effect.
Role: lead
A Trial of SHR-1701 in Subjects With Advanced Solid Tumors
Role: lead
A Trial of HTI-1090 in Subjects With Advanced Solid Tumors
Role: lead
A Phase I Trial of HS-10241 in Solid Tumors
Role: lead
A Trial of SHR3162 in Healthy Caucasian Volunteers
Role: lead
A Trial of SHR6390 in Healthy Caucasian Volunteers
Role: lead